Celltrion holdings Nasdaq

Hanwha Corp., the holding company of South Korea’s chemicals-to-defense conglomerate, will hive off its wind power and offshore plant building...

Korea Trade-Investment Promotion Agency (KOTRA) announced on Tuesday that the Korea-Kazakhstan Drone Roadshow opened in Astana, the capital of Kazak...

K Enter Holdings Inc., an umbrella entity of South Korea-based entertainment companies creating original entertainment content and managing related ...

South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...

Activist funds arm in arm to demand higher dividends from Samsung C&T Corp. got defeated in a proxy fight against the de facto holding firm of S...

The National Pension Service (NPS) will veto the appointment of the chairman and vice chairman of Hyosung Corp. as inside board members of the de fa...

The South Korean government on Monday tapped Mirae Asset Securities Co. as the brokerage chosen to sell treasury bonds, the sale of which will be la...

South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...

Samsung Electronics Co., the world’s largest memory chipmaker, saw its supremacy in the DRAM segment strengthen last year with its market shar...

HL Mando Corp., an electric vehicle and self-driving system developing unit of South Korea’s HL Group, said on Thursday it has launched an aut...

South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...

GS Holdings Corp., the holding company of South Korea’s energy-to-retail conglomerate GS Group, on Wednesday provided a dismal business outloo...

Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...

Mirae Asset Global Investments Co., one of the largest asset managers in South Korea, said on Thursday that its exchange-traded fund (ETF) TIGER US ...

South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

South Korea’s Hyundai Motor Group kept its title as the world's third-largest automaker by sales volume for the second straight year in 2023, ...

Lotte Duty Free held a grand opening ceremony for its Changi Airport store in Singapore, marking the official start of its 19 stores.Lotte Duty Free...

South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, picked information tech, electric and electronic s...

South Korea’s second-largest automaker Kia Corp. plans to establish a sales subsidiary in Thailand as part of its electric vehicle push in the...

South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, saw the amount of listed local shares it owns rise...

South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

South Korea’s entertainment powerhouse CJ ENM Co. announced on Thursday that it will hold its annual K-pop festival KCON in Hong Kong for the ...

South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...